Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

286.92
+2.650.93%
Pre-market: 287.300.3800+0.13%07:32 EDT
Volume:189.62K
Turnover:54.31M
Market Cap:5.72B
PE:29.55
High:290.33
Open:285.73
Low:281.69
Close:284.27
52wk High:326.63
52wk Low:161.82
Shares:19.94M
Float Shares:19.35M
Volume Ratio:1.09
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:5.91
PE(LYR):46.81

Loading ...

Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2025

Major Issues Report

Form 8-K - Current report
Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Major Issues Report

Form 8-K - Current report
Aug 11, 2025

Major Issues Report

Form 8-K - Current report
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2025

Major Issues Report

Form 8-K - Current report
Jun 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities